BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 236 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $488,754 | +61.3% | 69,033 | +187.2% | 0.01% | +11.1% |
| Q3 2022 | $303,000 | +27.8% | 24,034 | +65.2% | 0.01% | +28.6% |
| Q1 2022 | $237,000 | +51.0% | 14,548 | +28.7% | 0.01% | +40.0% |
| Q4 2021 | $157,000 | -79.6% | 11,308 | -76.8% | 0.01% | -84.8% |
| Q2 2021 | $769,000 | +605.5% | 48,641 | +231.8% | 0.03% | +725.0% |
| Q4 2020 | $109,000 | +127.1% | 14,658 | +5.0% | 0.00% | +100.0% |
| Q3 2020 | $48,000 | -33.3% | 13,964 | -7.8% | 0.00% | 0.0% |
| Q2 2020 | $72,000 | +26.3% | 15,140 | -46.6% | 0.00% | 0.0% |
| Q1 2020 | $57,000 | -94.6% | 28,368 | -77.6% | 0.00% | -84.6% |
| Q1 2017 | $1,063,000 | +431.5% | 126,553 | +551.5% | 0.01% | +550.0% |
| Q4 2015 | $200,000 | – | 19,424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
| Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
| Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
| Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
| ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
| MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
| Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
| Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
| Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |